IF2A_HUMAN - dbPTM
IF2A_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID IF2A_HUMAN
UniProt AC P05198
Protein Name Eukaryotic translation initiation factor 2 subunit 1
Gene Name EIF2S1
Organism Homo sapiens (Human).
Sequence Length 315
Subcellular Localization Cytoplasm, Stress granule . Colocalizes with NANOS3 in the stress granules.
Protein Description Functions in the early steps of protein synthesis by forming a ternary complex with GTP and initiator tRNA. This complex binds to a 40S ribosomal subunit, followed by mRNA binding to form a 43S pre-initiation complex. Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF-2 and release of an eIF-2-GDP binary complex. In order for eIF-2 to recycle and catalyze another round of initiation, the GDP bound to eIF-2 must exchange with GTP by way of a reaction catalyzed by eIF-2B..
Protein Sequence MPGLSCRFYQHKFPEVEDVVMVNVRSIAEMGAYVSLLEYNNIEGMILLSELSRRRIRSINKLIRIGRNECVVVIRVDKEKGYIDLSKRRVSPEEAIKCEDKFTKSKTVYSILRHVAEVLEYTKDEQLESLFQRTAWVFDDKYKRPGYGAYDAFKHAVSDPSILDSLDLNEDEREVLINNINRRLTPQAVKIRADIEVACYGYEGIDAVKEALRAGLNCSTENMPIKINLIAPPRYVMTTTTLERTEGLSVLSQAMAVIKEKIEEKRGVFNVQMEPKVVTDTDETELARQMERLERENAEVDGDDDAEEMEAKAED
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
9PhosphorylationPGLSCRFYQHKFPEV
CCCCCEEEECCCCCC
7.1429496907
12AcetylationSCRFYQHKFPEVEDV
CCEEEECCCCCCEEE
47.2726051181
12UbiquitinationSCRFYQHKFPEVEDV
CCEEEECCCCCCEEE
47.27-
26PhosphorylationVVMVNVRSIAEMGAY
EEEEEHHHHHHHCCE
23.1326552605
33PhosphorylationSIAEMGAYVSLLEYN
HHHHHCCEEEEEHCC
5.7127251275
35PhosphorylationAEMGAYVSLLEYNNI
HHHCCEEEEEHCCCC
17.9827251275
39PhosphorylationAYVSLLEYNNIEGMI
CEEEEEHCCCCCHHH
17.3027251275
49PhosphorylationIEGMILLSELSRRRI
CCHHHHHHHHHHHHH
32.8021082442
52PhosphorylationMILLSELSRRRIRSI
HHHHHHHHHHHHHHH
21.4914676213
58PhosphorylationLSRRRIRSINKLIRI
HHHHHHHHHHHHHHC
28.3020068231
61UbiquitinationRRIRSINKLIRIGRN
HHHHHHHHHHHCCCC
43.5521890473
61MalonylationRRIRSINKLIRIGRN
HHHHHHHHHHHCCCC
43.5526320211
61AcetylationRRIRSINKLIRIGRN
HHHHHHHHHHHCCCC
43.5525953088
78UbiquitinationVVVIRVDKEKGYIDL
EEEEEEECCCCEEEC
59.47-
80UbiquitinationVIRVDKEKGYIDLSK
EEEEECCCCEEECCC
63.86-
802-HydroxyisobutyrylationVIRVDKEKGYIDLSK
EEEEECCCCEEECCC
63.86-
82PhosphorylationRVDKEKGYIDLSKRR
EEECCCCEEECCCCC
11.4328152594
86PhosphorylationEKGYIDLSKRRVSPE
CCCEEECCCCCCCHH
21.9924719451
872-HydroxyisobutyrylationKGYIDLSKRRVSPEE
CCEEECCCCCCCHHH
52.07-
87AcetylationKGYIDLSKRRVSPEE
CCEEECCCCCCCHHH
52.0725953088
87UbiquitinationKGYIDLSKRRVSPEE
CCEEECCCCCCCHHH
52.0721906983
91PhosphorylationDLSKRRVSPEEAIKC
ECCCCCCCHHHHHCC
25.4523927012
97UbiquitinationVSPEEAIKCEDKFTK
CCHHHHHCCCHHCCC
38.32-
97AcetylationVSPEEAIKCEDKFTK
CCHHHHHCCCHHCCC
38.3226051181
101AcetylationEAIKCEDKFTKSKTV
HHHCCCHHCCCHHHH
32.4125825284
101UbiquitinationEAIKCEDKFTKSKTV
HHHCCCHHCCCHHHH
32.41-
103PhosphorylationIKCEDKFTKSKTVYS
HCCCHHCCCHHHHHH
39.9023312004
104UbiquitinationKCEDKFTKSKTVYSI
CCCHHCCCHHHHHHH
53.76-
106MalonylationEDKFTKSKTVYSILR
CHHCCCHHHHHHHHH
43.4926320211
106UbiquitinationEDKFTKSKTVYSILR
CHHCCCHHHHHHHHH
43.4921890473
107PhosphorylationDKFTKSKTVYSILRH
HHCCCHHHHHHHHHH
31.5923186163
109PhosphorylationFTKSKTVYSILRHVA
CCCHHHHHHHHHHHH
8.6728152594
110PhosphorylationTKSKTVYSILRHVAE
CCHHHHHHHHHHHHH
15.7121815630
123UbiquitinationAEVLEYTKDEQLESL
HHHHHHCCHHHHHHH
59.3721906983
1232-HydroxyisobutyrylationAEVLEYTKDEQLESL
HHHHHHCCHHHHHHH
59.37-
123AcetylationAEVLEYTKDEQLESL
HHHHHHCCHHHHHHH
59.3726051181
133MethylationQLESLFQRTAWVFDD
HHHHHHHHHHHHCCC
21.05-
1412-HydroxyisobutyrylationTAWVFDDKYKRPGYG
HHHHCCCCCCCCCCC
55.29-
141AcetylationTAWVFDDKYKRPGYG
HHHHCCCCCCCCCCC
55.2919608861
141UbiquitinationTAWVFDDKYKRPGYG
HHHHCCCCCCCCCCC
55.2921890473
143MalonylationWVFDDKYKRPGYGAY
HHCCCCCCCCCCCHH
58.8332601280
143AcetylationWVFDDKYKRPGYGAY
HHCCCCCCCCCCCHH
58.8326051181
143UbiquitinationWVFDDKYKRPGYGAY
HHCCCCCCCCCCCHH
58.8321890473
147PhosphorylationDKYKRPGYGAYDAFK
CCCCCCCCCHHHHHH
10.9828152594
150PhosphorylationKRPGYGAYDAFKHAV
CCCCCCHHHHHHHHC
11.9328152594
154UbiquitinationYGAYDAFKHAVSDPS
CCHHHHHHHHCCCHH
32.1621906983
154MethylationYGAYDAFKHAVSDPS
CCHHHHHHHHCCCHH
32.16-
158PhosphorylationDAFKHAVSDPSILDS
HHHHHHCCCHHHHHC
44.5830266825
161PhosphorylationKHAVSDPSILDSLDL
HHHCCCHHHHHCCCC
40.5523663014
165PhosphorylationSDPSILDSLDLNEDE
CCHHHHHCCCCCHHH
21.9729214152
185PhosphorylationNNINRRLTPQAVKIR
HHHHCCCCCCCEEEC
16.1430266825
190UbiquitinationRLTPQAVKIRADIEV
CCCCCCEEECCCEEE
29.501906983
1902-HydroxyisobutyrylationRLTPQAVKIRADIEV
CCCCCCEEECCCEEE
29.50-
199GlutathionylationRADIEVACYGYEGID
CCCEEEEECCCCCHH
3.0622555962
200PhosphorylationADIEVACYGYEGIDA
CCEEEEECCCCCHHH
17.0122817900
202PhosphorylationIEVACYGYEGIDAVK
EEEEECCCCCHHHHH
5.6327642862
209UbiquitinationYEGIDAVKEALRAGL
CCCHHHHHHHHHCCC
38.70-
219O-linked_GlycosylationLRAGLNCSTENMPIK
HHCCCCCCCCCCCEE
37.3728657654
219PhosphorylationLRAGLNCSTENMPIK
HHCCCCCCCCCCCEE
37.3721712546
223SulfoxidationLNCSTENMPIKINLI
CCCCCCCCCEEEEEE
2.7121406390
226UbiquitinationSTENMPIKINLIAPP
CCCCCCEEEEEECCC
21.48-
235PhosphorylationNLIAPPRYVMTTTTL
EEECCCCEEEEECCE
10.5929496907
237SulfoxidationIAPPRYVMTTTTLER
ECCCCEEEEECCEEC
1.7230846556
239O-linked_GlycosylationPPRYVMTTTTLERTE
CCCEEEEECCEECCC
10.3328657654
240O-linked_GlycosylationPRYVMTTTTLERTEG
CCEEEEECCEECCCC
21.8828657654
241O-linked_GlycosylationRYVMTTTTLERTEGL
CEEEEECCEECCCCH
25.2428657654
245PhosphorylationTTTTLERTEGLSVLS
EECCEECCCCHHHHH
25.6521406692
249PhosphorylationLERTEGLSVLSQAMA
EECCCCHHHHHHHHH
31.6921406692
252PhosphorylationTEGLSVLSQAMAVIK
CCCHHHHHHHHHHHH
17.4621406692
259UbiquitinationSQAMAVIKEKIEEKR
HHHHHHHHHHHHHHC
46.4821906983
261UbiquitinationAMAVIKEKIEEKRGV
HHHHHHHHHHHHCCC
50.87-
265UbiquitinationIKEKIEEKRGVFNVQ
HHHHHHHHCCCCEEE
41.48-
266MethylationKEKIEEKRGVFNVQM
HHHHHHHCCCCEEEE
50.19-
273SulfoxidationRGVFNVQMEPKVVTD
CCCCEEEECCEEECC
9.1921406390
276UbiquitinationFNVQMEPKVVTDTDE
CEEEECCEEECCCCH
35.7121906983
276AcetylationFNVQMEPKVVTDTDE
CEEEECCEEECCCCH
35.7126051181
279PhosphorylationQMEPKVVTDTDETEL
EECCEEECCCCHHHH
35.8530266825
281PhosphorylationEPKVVTDTDETELAR
CCEEECCCCHHHHHH
26.7730266825
284PhosphorylationVVTDTDETELARQME
EECCCCHHHHHHHHH
38.8230266825
309SulfoxidationGDDDAEEMEAKAED-
CCCCHHHHHHHHCC-
4.5828465586
312UbiquitinationDAEEMEAKAED----
CHHHHHHHHCC----
38.72-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
49SPhosphorylationKinaseEIF2AK1Q9BQI3
GPS
49SPhosphorylationKinaseEIF2AK2P19525
GPS
49SPhosphorylationKinaseEIF2AK3Q9NZJ5
GPS
52SPhosphorylationKinaseEIF2AK1Q9BQI3
GPS
52SPhosphorylationKinaseEIF2AK2P19525
GPS
52SPhosphorylationKinaseEIF2AK3Q9NZJ5
GPS
52SPhosphorylationKinasePERKQ9Z2B5
PSP
52SPhosphorylationKinaseRPS6KA3P51812
GPS
52SPhosphorylationKinaseMAPK1P28482
GPS
52SPhosphorylationKinaseMAPK14Q16539
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
49SPhosphorylation

15207627
52SPhosphorylation

18032499
52SPhosphorylation

15207627

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of IF2A_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
EI2BA_HUMANEIF2B1physical
9446619
E2AK2_HUMANEIF2AK2physical
19364808
IF2B_HUMANEIF2S2physical
22939629
IF2G_HUMANEIF2S3physical
22939629
POP1_HUMANPOP1physical
22939629
TMED9_HUMANTMED9physical
22939629
NCOA5_HUMANNCOA5physical
22939629
STRN_HUMANSTRNphysical
22939629
YBOX1_HUMANYBX1physical
22939629
AIMP1_HUMANAIMP1physical
22863883
SYDC_HUMANDARSphysical
22863883
MCA3_HUMANEEF1E1physical
22863883
IF2G_HUMANEIF2S3physical
22863883
MAP4_HUMANMAP4physical
22863883
SYMC_HUMANMARSphysical
22863883
SYQ_HUMANQARSphysical
22863883
RL13_HUMANRPL13physical
22863883
RL15_HUMANRPL15physical
22863883
RL27A_HUMANRPL27Aphysical
22863883
RL7A_HUMANRPL7Aphysical
22863883
RLA0_HUMANRPLP0physical
22863883
RS27L_HUMANRPS27Lphysical
22863883
IF2G_HUMANEIF2S3physical
26344197
RPB7_HUMANPOLR2Gphysical
26344197
RPN1_HUMANRPN1physical
26344197
TOE1_HUMANTOE1physical
26344197
CDC37_HUMANCDC37physical
12930845
HS90A_HUMANHSP90AA1physical
12930845

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of IF2A_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-141, AND MASS SPECTROMETRY.

TOP